Rochester Medical Director Schnobrich To Retire
STEWARTVILLE, Minn., Dec. 23, 2011 /PRNewswire/ -- Rochester Medical Corporation (Nasdaq: ROCM) announced today that Roger W. Schnobrich will retire from its Board of Directors following the conclusion of the Company's 2012 Annual Meeting of Shareholders to be held on January 26, 2012, which is the end of his current term.
Board Chairman and CEO Anthony J. Conway stated that "Mr. Schnobrich has served on our Board since 1995. His cheerful intelligence and gracious temperament have served the Company well. He is a man of excellent character and dignity, and Rochester Medical Corporation has benefited greatly from these traits over the years.
"Our many thanks for working with us, Roger. I know you will continue to enjoy each day."Conway continued, "I am very pleased to announce that the Board of Directors has nominated Peter H. Shepard for election as a Director for Rochester Medical Corporation at the 2012 Annual Meeting. Mr. Shepard has deep knowledge and experience in the medical device industry and is particularly expert in the field of Urology and Incontinence. Mr. Shepard's extensive sales and marketing experience will enable him to provide valuable insight and guidance to our management team with respect to our strategic initiatives to grow sales domestically and internationally." About Rochester Medical Corporation Rochester Medical Corporation develops, manufactures, and markets disposable medical catheters and devices for urological and continence care applications. The Company also sells certain ostomy and wound and scar care products and other brands of urological products into the European marketplace. For further information, please contact Anthony J. Conway, President and Chief Executive Officer or David A. Jonas, Chief Financial Officer of Rochester Medical Corporation at (507) 533-9600 or Parice Halbert, CFA, at Westwicke Partners (443) 213-0500. More information about the 2012 Annual Meeting of Shareholders is included in the Company's proxy statement filed with the Securities and Exchange Commission on December 23, 2011. More information about Rochester Medical is available on its website at http://www.rocm.com. SOURCE Rochester Medical Corporation
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV